In vivo and in vitro effects of pilocarpine: Relevance to ictogenesis

Nicola Marchi, Emily Oby, Ayush Batra, Laura Uva, Marco De Curtis, Nadia Hernandez, Anette Van Boxel-Dezaire, Imad Najm, Damir Janigro

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

Objectives: A common experimental model of status epilepticus (SE) utilizes intraperitoneal administration of the cholinergic agonist pilocarpine preceded by methyl-scopolamine treatment. Currently, activation of cholinergic neurons is recognized as the only factor triggering pilocarpine SE. However, cholinergic receptors are also widely distributed systemically and pretreatment with methyl-scopolamine may not be sufficient to counteract the effects of systemically injected pilocarpine. The extent of such peripheral events and the contribution to SE are unknown and the possibility that pilocarpine also induces SE by peripheral actions is yet untested. Methods: We measured in vivo at onset of SE: brain and blood pilocarpine levels, blood-brain barrier (BBB) permeability, T-lymphocyte activation and serum levels of IL-1β and TNF-α. The effects of pilocarpine on neuronal excitability was assessed in vitro on hippocampal slices or whole guinea pig brain preparations in presence of physiologic or elevated [K+]out. Results: Pilocarpine blood and brain levels at SE were 1400 ± 200 μM and 200 ± 80 μM, respectively. In vivo, after pilocarpine injection, increased serum IL-1β, decreased CD4:CD8 T-lymphocyte ratios and focal BBB leakage were observed. In vitro, pilocarpine failed to exert significant synchronized epileptiform activity when applied at concentrations identical or higher to levels measured in vivo. Intense electrographic seizure-like events occurred only in the copresence of levels of K+ (6 mM) mimicking BBB leakage. Conclusions: Early systemic events increasing BBB permeability may promote entry of cofactors (e. g. K+) into the brain leading to pilocarpine-induced SE. Disturbance of brain homeostasis represents an etiological factor contributing to pilocarpine seizures.

Original languageEnglish
Pages (from-to)1934-1946
Number of pages13
JournalEpilepsia
Volume48
Issue number10
DOIs
Publication statusPublished - Oct 2007

Fingerprint

Pilocarpine
Status Epilepticus
Blood-Brain Barrier
Brain
Scopolamine Hydrobromide
Interleukin-1
Permeability
Seizures
In Vitro Techniques
T-Lymphocytes
Cholinergic Agonists
Cholinergic Neurons
Cholinergic Receptors
Lymphocyte Activation
Serum
Guinea Pigs
Homeostasis
Theoretical Models

Keywords

  • Blood-brain barrier
  • Electrophysiology
  • Inflammation
  • Muscarinic receptors
  • Status epilepticus

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Marchi, N., Oby, E., Batra, A., Uva, L., De Curtis, M., Hernandez, N., ... Janigro, D. (2007). In vivo and in vitro effects of pilocarpine: Relevance to ictogenesis. Epilepsia, 48(10), 1934-1946. https://doi.org/10.1111/j.1528-1167.2007.01185.x

In vivo and in vitro effects of pilocarpine : Relevance to ictogenesis. / Marchi, Nicola; Oby, Emily; Batra, Ayush; Uva, Laura; De Curtis, Marco; Hernandez, Nadia; Van Boxel-Dezaire, Anette; Najm, Imad; Janigro, Damir.

In: Epilepsia, Vol. 48, No. 10, 10.2007, p. 1934-1946.

Research output: Contribution to journalArticle

Marchi, N, Oby, E, Batra, A, Uva, L, De Curtis, M, Hernandez, N, Van Boxel-Dezaire, A, Najm, I & Janigro, D 2007, 'In vivo and in vitro effects of pilocarpine: Relevance to ictogenesis', Epilepsia, vol. 48, no. 10, pp. 1934-1946. https://doi.org/10.1111/j.1528-1167.2007.01185.x
Marchi, Nicola ; Oby, Emily ; Batra, Ayush ; Uva, Laura ; De Curtis, Marco ; Hernandez, Nadia ; Van Boxel-Dezaire, Anette ; Najm, Imad ; Janigro, Damir. / In vivo and in vitro effects of pilocarpine : Relevance to ictogenesis. In: Epilepsia. 2007 ; Vol. 48, No. 10. pp. 1934-1946.
@article{65051eb560d643b59abcc3ebdf298930,
title = "In vivo and in vitro effects of pilocarpine: Relevance to ictogenesis",
abstract = "Objectives: A common experimental model of status epilepticus (SE) utilizes intraperitoneal administration of the cholinergic agonist pilocarpine preceded by methyl-scopolamine treatment. Currently, activation of cholinergic neurons is recognized as the only factor triggering pilocarpine SE. However, cholinergic receptors are also widely distributed systemically and pretreatment with methyl-scopolamine may not be sufficient to counteract the effects of systemically injected pilocarpine. The extent of such peripheral events and the contribution to SE are unknown and the possibility that pilocarpine also induces SE by peripheral actions is yet untested. Methods: We measured in vivo at onset of SE: brain and blood pilocarpine levels, blood-brain barrier (BBB) permeability, T-lymphocyte activation and serum levels of IL-1β and TNF-α. The effects of pilocarpine on neuronal excitability was assessed in vitro on hippocampal slices or whole guinea pig brain preparations in presence of physiologic or elevated [K+]out. Results: Pilocarpine blood and brain levels at SE were 1400 ± 200 μM and 200 ± 80 μM, respectively. In vivo, after pilocarpine injection, increased serum IL-1β, decreased CD4:CD8 T-lymphocyte ratios and focal BBB leakage were observed. In vitro, pilocarpine failed to exert significant synchronized epileptiform activity when applied at concentrations identical or higher to levels measured in vivo. Intense electrographic seizure-like events occurred only in the copresence of levels of K+ (6 mM) mimicking BBB leakage. Conclusions: Early systemic events increasing BBB permeability may promote entry of cofactors (e. g. K+) into the brain leading to pilocarpine-induced SE. Disturbance of brain homeostasis represents an etiological factor contributing to pilocarpine seizures.",
keywords = "Blood-brain barrier, Electrophysiology, Inflammation, Muscarinic receptors, Status epilepticus",
author = "Nicola Marchi and Emily Oby and Ayush Batra and Laura Uva and {De Curtis}, Marco and Nadia Hernandez and {Van Boxel-Dezaire}, Anette and Imad Najm and Damir Janigro",
year = "2007",
month = "10",
doi = "10.1111/j.1528-1167.2007.01185.x",
language = "English",
volume = "48",
pages = "1934--1946",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "10",

}

TY - JOUR

T1 - In vivo and in vitro effects of pilocarpine

T2 - Relevance to ictogenesis

AU - Marchi, Nicola

AU - Oby, Emily

AU - Batra, Ayush

AU - Uva, Laura

AU - De Curtis, Marco

AU - Hernandez, Nadia

AU - Van Boxel-Dezaire, Anette

AU - Najm, Imad

AU - Janigro, Damir

PY - 2007/10

Y1 - 2007/10

N2 - Objectives: A common experimental model of status epilepticus (SE) utilizes intraperitoneal administration of the cholinergic agonist pilocarpine preceded by methyl-scopolamine treatment. Currently, activation of cholinergic neurons is recognized as the only factor triggering pilocarpine SE. However, cholinergic receptors are also widely distributed systemically and pretreatment with methyl-scopolamine may not be sufficient to counteract the effects of systemically injected pilocarpine. The extent of such peripheral events and the contribution to SE are unknown and the possibility that pilocarpine also induces SE by peripheral actions is yet untested. Methods: We measured in vivo at onset of SE: brain and blood pilocarpine levels, blood-brain barrier (BBB) permeability, T-lymphocyte activation and serum levels of IL-1β and TNF-α. The effects of pilocarpine on neuronal excitability was assessed in vitro on hippocampal slices or whole guinea pig brain preparations in presence of physiologic or elevated [K+]out. Results: Pilocarpine blood and brain levels at SE were 1400 ± 200 μM and 200 ± 80 μM, respectively. In vivo, after pilocarpine injection, increased serum IL-1β, decreased CD4:CD8 T-lymphocyte ratios and focal BBB leakage were observed. In vitro, pilocarpine failed to exert significant synchronized epileptiform activity when applied at concentrations identical or higher to levels measured in vivo. Intense electrographic seizure-like events occurred only in the copresence of levels of K+ (6 mM) mimicking BBB leakage. Conclusions: Early systemic events increasing BBB permeability may promote entry of cofactors (e. g. K+) into the brain leading to pilocarpine-induced SE. Disturbance of brain homeostasis represents an etiological factor contributing to pilocarpine seizures.

AB - Objectives: A common experimental model of status epilepticus (SE) utilizes intraperitoneal administration of the cholinergic agonist pilocarpine preceded by methyl-scopolamine treatment. Currently, activation of cholinergic neurons is recognized as the only factor triggering pilocarpine SE. However, cholinergic receptors are also widely distributed systemically and pretreatment with methyl-scopolamine may not be sufficient to counteract the effects of systemically injected pilocarpine. The extent of such peripheral events and the contribution to SE are unknown and the possibility that pilocarpine also induces SE by peripheral actions is yet untested. Methods: We measured in vivo at onset of SE: brain and blood pilocarpine levels, blood-brain barrier (BBB) permeability, T-lymphocyte activation and serum levels of IL-1β and TNF-α. The effects of pilocarpine on neuronal excitability was assessed in vitro on hippocampal slices or whole guinea pig brain preparations in presence of physiologic or elevated [K+]out. Results: Pilocarpine blood and brain levels at SE were 1400 ± 200 μM and 200 ± 80 μM, respectively. In vivo, after pilocarpine injection, increased serum IL-1β, decreased CD4:CD8 T-lymphocyte ratios and focal BBB leakage were observed. In vitro, pilocarpine failed to exert significant synchronized epileptiform activity when applied at concentrations identical or higher to levels measured in vivo. Intense electrographic seizure-like events occurred only in the copresence of levels of K+ (6 mM) mimicking BBB leakage. Conclusions: Early systemic events increasing BBB permeability may promote entry of cofactors (e. g. K+) into the brain leading to pilocarpine-induced SE. Disturbance of brain homeostasis represents an etiological factor contributing to pilocarpine seizures.

KW - Blood-brain barrier

KW - Electrophysiology

KW - Inflammation

KW - Muscarinic receptors

KW - Status epilepticus

UR - http://www.scopus.com/inward/record.url?scp=35148890786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35148890786&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1167.2007.01185.x

DO - 10.1111/j.1528-1167.2007.01185.x

M3 - Article

C2 - 17645533

AN - SCOPUS:35148890786

VL - 48

SP - 1934

EP - 1946

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 10

ER -